ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

Detalles Bibliográficos
Autores principales: Mei, Ying, Hang, Qinglei, Teng, Hongqi, Yao, Fan, Chen, Mei-Kuang, Hung, Mien-Chie, Sun, Yutong, Ma, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363626/
https://www.ncbi.nlm.nih.gov/pubmed/37492703
http://dx.doi.org/10.1016/j.gendis.2022.09.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363626/
https://www.ncbi.nlm.nih.gov/pubmed/37492703
http://dx.doi.org/10.1016/j.gendis.2022.09.013

Ejemplares similares